Search the Newsreel

PROCEPT delivers 65 robotic systems as U.S. procedures pass 13,100

PROCEPT BioRobotics reported strong Q2 2026 financial results, with revenue up 19% year-over-year to $94.5 million, driven by increased U.S. handpiece, system sales, and international revenue. The company delivered 65 U.S. HYDROS robotic systems and U.S. procedures exceeded 13,100, marking a 21% increase. While …

Earnings Flash (PRCT) PROCEPT BioRobotics Corporation Reports Q2 Revenue $94.5M, vs. FactSet Est of $92.8M

Earnings To Watch: PROCEPT BioRobotics Corp (PRCT) Q2 2026 -- GF Value Sees 552% Upside

PROCEPT BioRobotics Corp (PRCT) is preparing to release its Q2 2026 earnings on August 4, 2026, with revenue expected at $92.89 million and an estimated loss of $-0.46 per share. Despite recent declines in full-year revenue and earnings estimates for 2026, the company's previous …

INVESTOR ALERT: RGRD Law Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead the Procept Class Action Lawsuit - PRCT

Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that Procept made materially false and misleading …

Did You Lose Money Investing in PROCEPT BioRobotics Corporation? Contact Robbins LLP for Information About Leading the Class Action Lawsuit Against PRCT

Robbins LLP is reminding investors that a securities class action lawsuit has been filed against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) for allegedly making false or misleading statements between February 28, 2024, and February 25, 2026. The lawsuit claims PROCEPT inflated its reported U.S. handpiece …

PROCEPT BioRobotics Corp. Revenue Breakdown – BIVA:PRCT

PROCEPT BioRobotics Corp. (PRCT) generated 5.55 billion MXN in revenue last year, with its Hand Pieces and Other Consumables segment contributing 3.27 billion MXN. The United States was the primary revenue source, accounting for 4.87 billion MXN. This financial overview highlights the company's key …

PROCEPT BioRobotics (PRCT) Faces Securities Class Action Amid Sales Pull-In Concerns - HBSS

PROCEPT BioRobotics (PRCT) is facing a securities class action lawsuit filed by Hagens Berman. The lawsuit alleges that the company engaged in a bulk discount program to pull in handpiece sales, artificially inflating reported unit sales and revenues, leading to significant investor losses. The …

Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm Before Lead Plaintiff Deadline on September 22, 2026

Kaplan Fox & Kilsheimer LLP has announced that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT falsely claimed …

Procept Biorobotics Corp (PRCT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Procept Biorobotics Corp (PRCT), evaluating its price momentum, support and resistance levels, and various technical indicators and moving averages. As of the analysis, PRCT's stock price is trading between a resistance of $22.50 and support of $15.08, …

PRCT|Procept Biorobotics Corp|Price:18.279|Chg%:+0.279

This article provides an overview of Procept Biorobotics Corp (PRCT), highlighting its current stock performance, key financial figures, and analyst ratings. The company, which specializes in surgical robotics for urology, has strong fundamentals and high growth potential despite recent stock market underperformance. Analysts rate …

PROCEPT BioRobotics Number of Employees 2026 | Employee Count & Headcount Data

PROCEPT BioRobotics Corp. (NASDAQ: PRCT) has seen significant employee growth, reaching 929 total employees worldwide as of March 2026, a 68.3% increase from 2023. The company is actively hiring, with 85 active job postings in 2026, and its workforce is primarily concentrated in the …

Should Alleged Undisclosed Discount Program and Excess Inventory Require Action From PROCEPT BioRobotics (PRCT) Investors?

ETFs Investing in PROCEPT BioRobotics Corp. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold PROCEPT BioRobotics Corp. (PRCT) stocks, providing key

BlackRock, Inc. (PRCT) discloses 4.65M-share, 8.2% holding in PROCEPT BioRobotics

BlackRock, Inc. has filed an amended Schedule 13G/A, disclosing its beneficial ownership of 4,646,656 shares of PROCEPT BioRobotics Corp. (PRCT), which represents an 8.2% stake in the company. BlackRock holds sole voting power over 4,558,571 shares and sole dispositive power over all 4,646,656 shares. …

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages PROCEPT

The Rosen Law Firm has announced a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT made materially false or misleading statements regarding …

PRCT Lawsuit Alert: PROCEPT BioRobotics Corp. Sued for Securities Fraud after that Undisclosed Discount Program Allegations Lead to 18% Stock Drop – Investors Notified to Contact BFA Law

Bleichmar Fonti & Auld LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) and its executives for securities fraud. The lawsuit alleges that PROCEPT artificially inflated its financial performance by using an undisclosed discount program that incentivized customers to place …

PROCEPT BioRobotics (PRCT) Projected to Release Quarterly Earnings on Tuesday

Procept Biorobotics Corp (PRCT) Balance Sheet

This article provides a detailed balance sheet for Procept Biorobotics Corp (PRCT), offering both quarterly and annual financial data. It includes key figures for assets (current and non-current), liabilities (current and non-current), and shareholders' equity across various fiscal quarters. The content also features an …

PRCT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead the Procept Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT), alleging violations of the Securities Exchange Act of 1934. The lawsuit claims that from February 28, 2024, to February 25, 2026, Procept made misleading statements by …

Procept Biorobotics Corp (PRCT) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Procept Biorobotics Corp (PRCT). It covers operating, investing, and financing cash flows, along with related financial metrics like capital expenditures and free cash flow. The report highlights the company's financial performance by …

Procept BioRobotics: Filling Robots Slower Than Placing Them (NASDAQ:PRCT)

Procept Biorobotics Corp (PRCT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Procept Biorobotics Corp (PRCT) by business segment and geographical region, with data updated on April 6. The company's revenue streams are primarily from hand pieces and other consumables, system sales and rentals, and service. The vast majority …

Procept Biorobotics Corp (PRCT) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Procept Biorobotics Corp (PRCT), highlighting its current earnings forecast score, average price target, and analyst ratings. It details expected revenue and EPS for upcoming quarters and includes a peer comparison in the Healthcare Equipment & Supplies industry. …

Procept Biorobotics Corp (PRCT) Income Statement

This article provides a detailed quarterly and annual income statement for Procept Biorobotics Corp (PRCT), offering insights into its financial performance, including total revenue, operating expenses, and net income. It also includes FAQs about interpreting income statements and key metrics for analyzing PRCT stock. …

PROCEPT BioRobotics (PRCT) Gains On Coverage And Trial Progress, Is The Stock Still Cheap?

PROCEPT BioRobotics (PRCT) has seen increased attention and a 12.57% share price return over seven days following Evercore ISI coverage and significant trial milestones, despite a 59.66% decline in its 1-year total shareholder return. The stock, currently trading below analyst price targets, is considered …